CYP17A1 and breast cancer: Compared to women with the common homozygous A1/A1 genotype a significantly lower risk of BC was observed among women with at least one variant CYP17 A2 allele (adjusted OR: 0.34; 95% CI: 0.12-0.94; p = 0.038) (Table 2).